MicroFlow Innovation Ltd. is a company grew out of a research team of Dr. Kangning Ren from Hong Kong Baptist University. We aim at bringing microfluidic techniques into development point-of-care-tests (POCTs) and studies of drug-resistant bacteria.

​

We aim to commercialize and make practical use of academic research findings on surveillance, prevention and control of infectious diseases, and are dedicated to developing and perfecting our innovative technologies to antimicrobial susceptibility tests (ASTs), surveillance of antimicrobial resistance (AMR) in environment and personalized medicine for clinical use; thus, revolutionizing the current healthcare and clinical practices, decreasing misuse and overuse of antibiotics and increasing life span of human.

 

To the best of our belief, we will provide effective strategies to prevent and control crisis caused by infectious diseases with our pioneering technologies in the near future.